Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    14627786 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Recruiting Safety and Efficacy Study of Etanercept (Qiangke®) to Treat Moderate to Severe Plaque Psoriasis
Conditions: Plaque Psoriasis;   Psoriasis
Interventions: Biological: etanercept;   Biological: etanercept (half dose);   Drug: placebo
2 Completed Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis
Conditions: Psoriasis;   Vascular Inflammation;   Coronary Atherosclerosis
Interventions: Biological: adalimumab;   Device: UVB Phototherapy;   Other: Topical treatment

Indicates status has not been verified in more than two years